Sahil A. Parikh, MD
@sahilparikhmd
Followers
3K
Following
1K
Media
10
Statuses
289
Interventional Cardiologist, Vascular Medicine, Clinician Educator and Clinical Researcher, Husband/Father, Friend. My views only; not medical advice.
New York, NY
Joined September 2018
🧵4/ A dissolving stent to restore blood flow in the lower leg—and hope for patients with severe artery disease. Dr. Sahil Parikh shared 3-year LIFE-BTK results in late-breaking clinical science at #TCT2025. @sahilparikhmd #CardioX #CardioEd
2
2
11
After #EspritBTK dissolves, the benefits remain. 📊 3-year LIFE-BTK RCT study results presented by Dr. @sahilparikhmd at #TCT2025 show 90% of patients did not require reintervention* through 3 years¹. See the data: https://t.co/urcf7KQHLm Safety Info: https://t.co/hYk12aSjvT
1
4
13
With more than 8,500 satellites in orbit, Starlink provides connectivity through harsh weather conditions, network disruptions, and natural disasters. Order online in under 2 minutes.
475
926
8K
Behind the Heart 💙 Meet Dr Sahil Parikh What inspired an interventional cardiologist to focus on peripheral vascular disease? 💬 "These patients are often ignored, but their outcomes - morbidity & mortality - exceed even those who have heart attacks."
0
2
8
We’re proud to honor Dr. Kenneth Rosenfield (@krosenfieldMD) as the #TCT2025 Master Operator Award recipient!🏆 With over 35 years of advancing patient care, he’s been a driving force in endovascular therapy — pioneering techniques, shaping technologies, and mentoring future
1
21
50
Are you under 40 and making waves in #interventionalcardiology? This is your moment to shine! ✨ Apply for the Linnemeier Award, a career-launching honor for emerging investigators in interventional cardiovascular medicine. Past winners are now global leaders. You could be
0
15
36
Registration is open for our 3rd Annual Cors/Vasc at the shore fellows program. Enjoy a weekend on the the beach in beautiful long branch with renowned faculty @RajTayalMD @CardiacConsult @SripalBangalore @SrihariNaiduMD @sahilparikhmd @PhilGenereuxMD @CraigMWalkerMD @SVRaoMD
1
9
22
The CRF Fellows Course Program Guide is LIVE! 🚀 🔹 Training. 🔹 Education. 🔹 Connection. Everything you need to shape your future in #interventionalcardiology is at #Fellows2025. Are you ready to take your career to the next level? https://t.co/AJMENd2pBt ⏳ Limited spots
0
6
13
"Avoiding these TLRs and avoiding these reinterventions is very important.” @derubertisMD @sahilparikhmd @MarcBonaca #VIVA2024
https://t.co/aJojs9jfGX
tctmd.com
The data thus far suggest fewer repeat interventions with the newly FDA approved resorbable device compared with PTA.
0
2
6
Still time to register for our dedicated vascular session with renowned faculty from multi specialities https://t.co/ZXbRvJrRwD in https://t.co/yAB1tTu8aH
@CorsAtTheShore @BillBeckerman @sahilparikhmd @SaqibZiaMD @CraigMWalkerMD @JayMathewsMD @jcgeorgemd
0
5
17
When Kimberly went in for a routine medical visit with her ob/gyn, she had no idea it would be the first step on a journey involving a life-threatening cardiac crisis and a heroic recovery. A blood clot formed in her lungs, and the team had to act fast. Read her remarkable
0
1
7
FDA Approves Bioresorbable Scaffold for BTK Lesions
tctmd.com
(UPDATED) The approval marks the return of the dissolving-scaffold concept, which so far has failed to find success in the coronaries.
0
3
10
Congratulations to @AlexandraLansky on presenting LIFE BTK as the top trial of 2023 at #ACC24. Great efforts for AGENT-IDE (@AGoldsweig), TRILUMINATE (@DrVivianNg) & ORBITA-2 (@KMavromatisMD).
2
1
14
Are you ready to elevate your career? 🚀 📣 We still have a few spots left for #Fellows2024 - and it’s FREE for qualifying fellows! Don’t let this amazing opportunity pass you by! ✨ https://t.co/FeqFtYjsGj
@sahilparikhmd @mbmcentegart @jgranadacrf @triciarawh @SVRaoMD
0
7
10
📚Curious about pt selection, device choice, & procedural planning for percutaneous mechanical aspiration in infective endocarditis? 🔎Read this review outlining a systematic approach, & tips & tricks for performing these interventions. ➡️ https://t.co/AtZVsKzCvH
1
8
21
🆕📢Call for Papers - The Role of Artificial Intelligence in Cardiovascular Interventions. 🎯 Submit your research on AI applications & innovative uses of AI in various cardiac diseases💡 ⏰Submit by Monday, June 17 Guest Editors: @YChatzizisis & Elazer Edelman MD PhD
2
8
20
Watch Now! This week's OPCI Journal Club features @sahilparikhmd presenting “Drug-Eluting Resorbable Scaffold vs. Balloon Angioplasty for Infrapopliteal Artery Disease" ”with panelists @djc795 @ziadalinyc @DrAllenJ and Dr. Lawrence Garcia. https://t.co/9bNP9b5IHm.
#CardioTwitter
0
6
8
🌟 Get ready for #Fellows2024. Apply or register today! 🌟 📍 Where: Las Vegas, NV | 📅 When: April 11-14, 2024 👉 Apply: https://t.co/FeqFtYjsGj 👉 Register: https://t.co/k9J53Mk3Jj
@sahilparikhmd @mbmcentegart @jgranadacrf @triciarawh @djc795 #CardioEd #CardioTwitter
0
6
13
Check out our recently published meta analysis in JEVT evaluating primary patency rates following PTA for BTK CLTI @sahilparikhmd @sanjum @AlexandraLansky
journals.sagepub.com
Purpose: Percutaneous transluminal angioplasty (PTA) remains the mainstay of endovascular therapy for infrapopliteal chronic limb-threatening ischemia (CLTI), b...
2
3
11
https://t.co/3uAd6aWtu8 This study represents a breakthrough for our patients. So grateful for the chance to help lead this trial with an amazing team.
19
29
217
Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?
tctmd.com
(UPDATED) After nearly 5 years, most at a TCT 2023 session agreed that the mystery of the paclitaxel signal has been solved.
0
2
13